Vitamin D supplements for aggressive non-Hodgkin lymphoma
Part of Blood & lymphatic, Cancer, Hormones & metabolism, Immune system & allergy clinical trials.
This study compares two doses of vitamin D to find the best way to raise low vitamin D levels in people being treated for aggressive non-Hodgkin lymphoma. It aims to see if a higher dose helps normalize vitamin D faster, which may support overall health during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older.
- You have been recently diagnosed with aggressive non-Hodgkin lymphoma and are about to start standard first-line chemotherapy with immunotherapy.
- You have low vitamin D levels (below 30 ng/mL) at the time of screening.
- Your overall health allows you to receive full-dose standard chemotherapy.
- You are not currently taking vitamin D supplements and have not had prior treatment for lymphoma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether a short “pre-treatment” with prednisone, with or without vitamin D, can improve outcomes when followed by standard lymphoma chemo. It aims to see if adding vitamin D early can help older adults tolerate or benefit from treatment for specific lymphoma types.
This trial tests whether taking vitamin A and D after a stem cell transplant can help improve recovery. It is for people with certain blood cancers who have a matched donor and are in remission or have low disease activity.
This early-phase study tests whether taking a Vitamin D3 supplement can be safe and helpful for people with symptomatic multiple myeloma. It may help researchers understand how Vitamin D affects the disease and how patients tolerate treatment.
This trial tests whether adding high-dose vitamin C (ascorbic acid) to standard chemotherapy helps treat lymphomas that have come back or not responded, as well as two related blood disorders (CCUS and CMML). The goal is to see if the vitamin C makes the chemo work better.
This trial tests whether taking vitamin D supplements can reduce side effects from chemotherapy in people with breast cancer. It is for patients with low vitamin D levels who are about to start their first chemotherapy treatment.
This study looks at how vitamin D levels affect treatment results in women with locally advanced cervical cancer who are about to start chemoradiation (chemotherapy plus radiation). It aims to see if higher vitamin D is linked to better outcomes.
Hear when a new Vitamin D 25-Hydroxylase Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.